Adaptive Biotechnologies Corp — insider transactions
15 transactions on record · ADPT · CIK 1478320
Aggregates
computed from the filings belowPurchases, 12m
0
count of open-market buys
Sales, 12m
15
count of open-market sales
Buy / sell ratio, 12m
0.00
purchases per sale
Distinct insiders, 12m
3
Bought, 3m
$0
Sold, 3m
$24.6M
Median disclosure lag
2.0 d
trade date to filing date
Largest single trade, 24m
$6.1M
2026-07-21
Director share, 12m
0.0%
of transactions where role is stated
Current run
15 sells
consecutive same-direction transactions
Net 3m flow
-$24.6M
purchases minus sales
Total on record
15
Transactions
15 most recent shown| Disclosed | Traded | Lag, d | Insider | Role | Transaction | Shares | Price | Value | Source |
|---|---|---|---|---|---|---|---|---|---|
| 2026-08-03 | 2026-07-30 | 4 | BOBULSKY SUSAN | Chief Commercial Officer, MRD | Open market sale | 1,299 | $24.00 | $31.2K | filing |
| 2026-07-23 | 2026-07-21 | 2 | ROBINS HARLAN S | Chief Scientific Officer | Exercise of derivative | 284,800 | $6.55 | $1.9M | filing |
| 2026-07-23 | 2026-07-21 | 2 | ROBINS HARLAN S | Chief Scientific Officer | Open market sale | 213,702 | $22.12 | $4.7M | filing |
| 2026-07-23 | 2026-07-21 | 2 | ROBINS HARLAN S | Chief Scientific Officer | Open market sale | 278,698 | $21.72 | $6.1M | filing |
| 2026-07-23 | 2026-07-21 | 2 | ROBINS HARLAN S | Chief Scientific Officer | Exercise of derivative | 284,800 | $0.00 | — | filing |
| 2026-07-20 | 2026-07-16 | 4 | BOBULSKY SUSAN | Chief Commercial Officer, MRD | Open market sale | 5,000 | $23.00 | $115K | filing |
| 2026-07-17 | 2026-07-15 | 2 | LO FRANCIS | Chief People Officer | Exercise of derivative | 22,711 | $8.46 | $192.1K | filing |
| 2026-07-17 | 2026-07-15 | 2 | LO FRANCIS | Chief People Officer | Exercise of derivative | 23,677 | $0.00 | — | filing |
| 2026-07-17 | 2026-07-15 | 2 | LO FRANCIS | Chief People Officer | Exercise of derivative | 59,374 | $7.80 | $463.1K | filing |
| 2026-07-17 | 2026-07-15 | 2 | LO FRANCIS | Chief People Officer | Open market sale | 105,762 | $22.59 | $2.4M | filing |
| 2026-07-17 | 2026-07-15 | 2 | LO FRANCIS | Chief People Officer | Exercise of derivative | 22,711 | $0.00 | — | filing |
| 2026-07-17 | 2026-07-15 | 2 | LO FRANCIS | Chief People Officer | Exercise of derivative | 23,677 | $12.14 | $287.4K | filing |
| 2026-07-17 | 2026-07-15 | 2 | LO FRANCIS | Chief People Officer | Exercise of derivative | 59,374 | $0.00 | — | filing |
| 2026-07-07 | 2026-07-02 | 5 | ROBINS HARLAN S | Chief Scientific Officer | Open market sale | 146,889 | $22.45 | $3.3M | filing |
| 2026-07-07 | 2026-07-02 | 5 | ROBINS HARLAN S | Chief Scientific Officer | Open market sale | 239,351 | $21.74 | $5.2M | filing |